Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Guido Trenn"'
Severe Upper Gastrointestinal Bleeding due to Ulcerative Eosinophilic Gastritis in a 79-Year-Old Man
Autor:
Merlin Wennmann, Guido Trenn
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 144:893-896
ZusammenfassungDie eosinophile gastrointestinale Erkrankung (EGID) ist ein seltenes Krankheitsbild weitgehend unklarer Ätiologie. Wir beschreiben im Folgenden den Fall eines 79-jährigen Patienten mit der Erstdiagnose einer eosinophilen Gastritis mi
Autor:
Heinz Dürk, Arnold Ganser, Jan Rekowski, Andreas Hertel, Bernd Hertenstein, Lars Kurch, Matthias Sandmann, Winfried Brenner, Christiane Kreisel-Büstgens, Christiane Franzius, Wolfram Klapper, Matthias Weckesser, Aristoteles Giagounidis, Martin Freesmeyer, Thomas Krohn, Volker Runde, Dirk Behringer, Michael Heike, Stefan P. Müller, Frank Kroschinsky, Regina Moeller, Rolf Larisch, Hubertus Hautzel, Christine Schmitz, Gerhard Heil, Rolf M. Mesters, Ulrich Dührsen, Karl-Heinz Jöckel, Ferras Alashkar, Helga Bernhard, Dietmar Wacker, Uwe M. Martens, Stefan Mahlmann, Stefan Wilop, Jörg Kotzerke, Ronald Boellaard, Paul La Rosée, Gabriele Prange-Krex, Andreas Hüttmann, Heinz Gert Hoeffkes, Uwe Haberkorn, Guido Trenn, Dieter Hoelzer, Marcus Brinkmann, Frank M. Bengel
Publikováno v:
Schmitz, C, Rekowski, J, Müller, S P, Hertenstein, B, Franzius, C, Ganser, A, Bengel, F M, Kroschinsky, F, Kotzerke, J, La Rosée, P, Freesmeyer, M, Hoeffkes, H G, Hertel, A, Behringer, D, Mesters, R, Weckesser, M, Mahlmann, S, Haberkorn, U, Martens, U, Prange-Krex, G, Brenner, W, Giagounidis, A, Moeller, R, Runde, V, Sandmann, M, Hautzel, H, Wilop, S, Krohn, T, Dürk, H, Heike, M, Alashkar, F, Brinkmann, M, Trenn, G, Wacker, D, Kreisel-Büstgens, C, Bernhard, H, Heil, G, Larisch, R, Kurch, L, Jöckel, K H, Hoelzer, D, Klapper, W, Boellaard, R, Dührsen, U & Hüttmann, A 2020, ' Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma : A subgroup analysis of the PETAL trial ', Hematological Oncology, vol. 38, no. 3, pp. 244-256 . https://doi.org/10.1002/hon.2697
Hematological Oncology, 38(3), 244-256. John Wiley and Sons Ltd
Hematological Oncology, 38(3), 244-256. John Wiley and Sons Ltd
The prospective randomized Positron Emission Tomography (PET)-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) trial was designed to test the ability of interim PET (iPET) to direct therapy. As reported previously, outcome remained unaffect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::099b8783f9b6d6dc0cff5a6c834fda48
https://research.vumc.nl/en/publications/15e83158-ea3b-4feb-ba8a-34400272cd82
https://research.vumc.nl/en/publications/15e83158-ea3b-4feb-ba8a-34400272cd82
Autor:
Andrea Tannapfel, Larissa Kluxen, Hendrik Juette, Christian Teschendorf, Berlinda Verdoodt, Stefanie Noepel-Duennebacke, Lars Engel, Anke Reinacher-Schick, Guido Trenn, Inke Sabine Feder, Metin Senkal, Heiner Wolters, Torsten Herzog, Waldemar Uhl, Lothar Mueller, Renate Klaassen-Mielke, Nadezda Basara, W. F. A. Hiller
Publikováno v:
Zeitschrift fur Gastroenterologie. 58(6)
Colorectal cancer is one of the leading malignancies and still accounts for almost 25 000 deaths in Germany each year. Although there is accumulating data on the molecular basis, treatment and clinical outcome of patients within clinical trials evide
Autor:
Dietrich W. Beelen, Peter Staib, Gero Massenkeil, Heidrun Hindahl, Andreas Faldum, Karsten Spiekermann, Stefan K. Bohlander, Anja Baumgartner, Christian Buske, Michael Unterhalt, Marion Subklewe, Dennis Görlich, Michael Fiegl, Gerald Meckenstock, Cristina Sauerland, Xaver Schiel, Guido Trenn, E. Roemer, Harald Biersack, Dirk Medgenberg, Birgit Braess, Raphael Koch, Bettina Zinngrebe, Jan Braess, Rainer Schwerdtfeger, Maike de Wit, Hans Walter Lindemann, Karl-Anton Kreuzer, Eva Lengfelder, Michael Uppenkamp, Dirk Behringer, Wolfgang Hiddemann, Ullrich Graeven, Ernst Spaeth-Schwalbe, Tobias Gaska, Bernhard Wörmann, Michael G. Kiehl, Stephanie Schneider, Stefan Korsten, Wolf-Dieter Ludwig, Susanne Amler, Rudolf Peceny, Martin Lablans, Yon-Dschun Ko, Annika Dufour
Publikováno v:
Leukemia
Dose-dense induction with the S-HAM regimen was compared to standard double induction therapy in adult patients with newly diagnosed acute myeloid leukemia. Patients were centrally randomized (1:1) between S-HAM (2nd chemotherapy cycle starting on da
Autor:
Torsten Ueberrueck, Anke Reinacher-Schick, Hendrik Juette, Inke Sabine Feder, Stefanie Noepel-Duennebacke, Thorsten Dahm, Alexander Leins, Dirk Arnold, Hinrich Boehner, Berlinda Verdoodt, Lothar Müller, Olaf Hansen, Nadine Zwingmann, Andrea Tannapfel, Nadezda Basara, W. F. A. Hiller, Christian Teschendorf, Guido Trenn, Waldemar Uhl
Publikováno v:
Journal of Clinical Oncology. 35:e15086-e15086
e15086 Background: High microsatellite instability (MSI-H) is a prognostic marker in resected colon cancer (CC) identified in post-hoc analysis of multiple trials. However, validation in real-life cohorts and its association with clinical and molecul
Autor:
Claudia Ose, Heinz Dürk, Agnieszka Korfel, Matthias Sandmann, Regina Moeller, Anke Franzke, Gerhard Heil, Jörg Kotzerke, Stefan Wilop, Wolfram Klapper, Matthias Weckesser, Winfried Brenner, Dirk Behringer, Andreas Hüttmann, Christiane Kreisel-Büstgens, Otto Kloke, Gabriele Prange-Krex, Aristoteles Giagounidis, Dirk Strumberg, Uwe M. Martens, Stefan Mahlmann, Karl-Heinz Jöckel, Thomas Krohn, Frank Kroschinsky, Uwe Haberkorn, Martin Freesmeyer, Bernd Hertenstein, Heinz-Gert Hoeffkes, Tu-Anh Dang, Paul La Rosée, Guido Trenn, Michael Heike, Andreas Hertel, Christiane Franzius, Ulrich Duehrsen, Hubertus Hautzel, Dieter Hoelzer, Marcus Brinkmann, Rolf M. Mesters, Jan Rekowski, Volker Runde, Frank M. Bengel, Stefan P. Müller
Publikováno v:
Blood. 128:185-185
Introduction: The PETAL trial is a multicenter randomized controlled study for patients with aggressive lymphomas of diverse histologies (EudraCT 2006-001641-33, NCT00554164). In the study population as a whole interim PET (iPET) reliably predicted t
Autor:
Guido Trenn, Ursula Kronawitter, Christoph Nerl, Rudolf Wei, Dirk Schürmann, Paris S. Mitrou, Clemens Scheidegger, Jan van Lunzen, Dieter Huhn, Keikawus Arastéh, Hermann Herbst, Wolfgang Knauf
Publikováno v:
Leukemia & Lymphoma. 29:103-118
In a prospective multicenter study 68 out of 158 patients with HIV infection and malignant lymphoma were assigned to a risk-adapted induction therapy using the following algorithm: High-risk patients fulfilled 2 of 3 criteria: T4 lymphocytes50/microL
Autor:
Torsten Haferlach, Guido Trenn, Claudia Schoch, Wolfgang Kern, Susanne Schnittger, Ulrike Bacher, Martin Weisser
Publikováno v:
Cancer Genetics and Cytogenetics. 168:172-174
We here report on an 48-year-old male patient with a primary diagnosis of acute myeloid leukemia (AML)-M2 with t(8;21)(q22;q22), who developed complete hematologic and molecular remission after induction chemotherapy. Thirteen months later, he relaps
Autor:
Teresa Halbsguth, Jana Markova, Helen Görgen, Martin Soekler, Boris Böll, Hans Theodor Eich, Henning Bredenfeld, Bastian von Tresckow, Peter Borchmann, Michael Fuchs, Andreas Engert, Michael Geissler, Dennis A. Eichenauer, Stephan Kremers, Ulrich Keller, Guido Trenn, Ullrich Graeven
Publikováno v:
Blood. 118(24)
Approximately 20% of all Hodgkin lymphoma (HL) patients are older than 60 years and have a poor prognosis, mainly because of increased treatment-related toxicity resulting in reduced overall dose intensity and more treatment-related mortality. To pos
Publikováno v:
Journal of Immunological Methods. 161:41-57
Using metabolic radiolabelling of proteins, which are newly synthesized during TCR-triggered T cell activation we were able to visualize distinct patterns of secreted polypeptides (with molecular weights ranging from 6 to 44 kDa) in supernatants of d